Related Experiment Video
Updated: May 25, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome
Takahisa Shiraishi1, Toshiyuki Yamamoto
1Department of Dermatology, Fukushima Medical University, Fukushima, Japan.
Abstract:
Dyshidrotic eczema is one of the rare cutaneous adverse effects of intravenous immunoglobulin therapy, usually seen in adults. We herein report the first pediatric case of severe dyshidrotic eczema occurring after intravenous immunoglobulin therapy for Kawasaki syndrome.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Rheumatic Heart Disease I: Introduction
Nephrotic Syndrome I : Introduction
Diphtheria